Repligen Corporation Stock News

Management has executed its strategy well, but a potential risk is looming.

Management has executed its strategy well, but a potential risk is looming.

Webcast and Conference Call to Be Held Wednesday, April 27, 2022 at 8:30 a.m. EDT Webcast and Conference Call to Be Held Wednesday, April 27, 2022 at 8:30 a.m. EDT

Webcast and Conference Call to Be Held Wednesday, April 27, 2022 at 8:30 a.m. EDT Webcast and Conference Call to Be Held Wednesday, April 27, 2022 at 8:30 a.m. EDT

If you follow an elephant's tracks, you find an elephant. If you follow a large money manager, you'll find the winners they've identified.

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Repligen and Exact Sciences have a proven track record with significant opportunities for continued growth.

Style Box ETF report for RFG

Style Box ETF report for IVOG

Smart Beta ETF report for PBE

WALTHAM, Mass., March 18, 2022 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present vi

WALTHAM, Mass., March 18, 2022 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will present virt

NEW YORK , March 15, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for RGEN, ZEN, UAL, DLTR, and BNTX. … Full story available on Benzinga.com

SAN FRANCISCO , March 10, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Biopharmaceutical Bioseparation Systems - Global Market Trajectory & Analytics" . The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace. FACTS AT A GLANCE What''s New for 2022? Global competitiveness and key competitor percentage market shares Market presence across multiple geographies - Strong/Active/Niche/Trivial Online interactive peer-to-peer collaborative bespoke updates Access to our digital archives and MarketGlass Research Platform Complimentary updates for one year Edition: 17; Released: February 2022 Executive Pool: 4113 Companies: 52 - Players covered include 3M Purification Inc.; Agilent Technologies, Inc.; Alfa Wassermann Separation Technologies LLC; Flottweg Separation Technology; GE Healthcare Life Sciences; GEA Westfalia Separator Group GmbH; KNAUER Wissenschaftliche Geräte GmbH; Konik Nanobiotech SL; Merck KGaA; Pall Corporation; ProMetic Life Sciences Inc.; Repligen Corp.; Sartorius Stedim Biotech; Thermo Fischer Scientific Inc.; Tosoh Bioscience Inc.; YMC Europe GMBH and Others.

LRT Capital Management, an investment management firm, published its fourth-quarter 2021 investor letter – a copy of which can be downloaded here.